ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AVBP ArriVent BioPharma Inc

18.70
-0.13 (-0.69%)
After Hours
Last Updated: 17:30:00
Delayed by 15 minutes

ArriVent BioPharma Financial Summary

The current AVBP market cap is 597.59M. The company's latest EPS is USD -2.1696 and P/E is -8.65.

Quarter End Dec 2023Mar 2024
USD ($)USD ($)
Total Revenue 00
Operating Income -23.12M-20.67M
Net Income -21.19M-17.42M
Year End December 30 2023 20222023
USD ($)USD ($)
Total Revenue 00
Operating Income -36.91M-74.59M
Net Income -36.91M-69.33M
Quarter End Dec 2023Mar 2024
USD ($)USD ($)
Total Assets 163.1M327.84M
Total Liabilities 11.8M10.12M
Total Equity -153.19M317.72M
Year End December 30 2023 20222023
USD ($)USD ($)
Total Assets 182.83M163.1M
Total Liabilities 8.37M11.8M
Total Equity -85.11M-153.19M
Quarter End Dec 2023Mar 2024
USD ($)USD ($)
Operating -55.84M-18.63M
Investing N/A N/A
Financing 42.86M185.63M
Year End December 30 2023 20222023
USD ($)USD ($)
Operating -43.63M-55.84M
Investing N/A N/A
Financing 169.72M42.86M
Market Cap 597.59M
Price to Earnings Ratio -8.65
Price to Sales Ratio 0
Price to Cash Ratio 3.99
Price to Book Ratio 3.96
Dividend Yield -

Share Statistics

Shares Outstanding 31.96M
Average Volume (1 week) 51.17k
Average Volume (1 Month) 46.63k
52 Week Change -22.08%
52 Week High 25.5076
52 Week Low 14.35
Spread (Intraday) 12.19 (53.02%)

Company Info

Company Name ArriVent BioPharma Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://arrivent.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock